India-based Accutest Biologics Private Limited (ABPL), a CRO for Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the OECD-Good Laboratory Practice (GLP) certification. Accutest claims that the said approval is the first inIndiafor any independent laboratory without an animal house.

 

The GLP Certification is in recognition of the high-quality, regulatorily compliant services rendered by Accutest in validating the processes and documentation systems followed at the test facility. “The certification places Accutest in a select league of CROs that have been awarded such a global honor. It is a matter of pride and privilege for Accutest not only to serve the biopharma industry with established credibility but also to get recognized in all the OECD member countries for mutual acceptance of data," commented Dr.Satish Sawant, Founder of Accutest.

 

“ABPL has been in existence for more than 5 years and conducted various studies for submissions across USFDA, EMA, DCGI and ANVISA. This approval will enable us to advance rapidly as a global service provider servicing the biopharmaceutical industry while maintaining high quality deliverables,” said Dr.Mallikarjun Dixit, President R&D and Test Facility Managementat ABPL.

The GLP Certification is in recognition of the high-quality, regulatorily compliant services rendered by Accutest in validating the processes and documentation systems followed at the test facility.